Delivery Order SPE2DB22D2103-SPE2DB25FR9RQ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency for the supply of Vyndamax 61 mg capsules in unit dose packs of 30, with a ceiling value of $13,846.97. This firm fixed-price delivery order, which is not set aside for any particular business category, is scheduled for ultimate completion by September 3, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30 count). This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 4, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Vyndamax is a branded pharmaceutical used in the treatment of cardiac amyloidosis...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on August 14, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) under a firm fixed price contract. The delivery order, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. Performance will be executed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is a child contract awarded...
- The Defense Logistics Agency awarded a delivery order valued at $83,081.82 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This firm fixed price delivery order, which carries an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) valued at $69,234.85. The award was made on a firm fixed price basis with no set-aside designation, indicating competitive selection among qualified vendors. This delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging of 30-count bottles. This is a firm fixed price delivery order with a ceiling value of $13,846.97 and an ultimate completion date of August 18, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $27,693.94 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on August 14, 2025, with completion targeted for September 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award under open procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is fulfilling this order through its location in the same city...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9RQDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $27,693.94 on August 15, 2025. The contract involves the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30, with an ultimate completion date of September 8, 2025. This is a firm fixed price, non-set-aside delivery order with performance at the vendor's Conshohocken facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Vyndamax is a brand-name pharmaceutical product used for the treatment of transthyretin cardiac amyloidosis. This delivery order exemplifies the company's extensive portfolio of federal medical product deliveries, which encompasses specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded, non-set-aside contracts through the DLA demonstrates the vendor's established capability to meet federal procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 8/15/25 |